In animal models of renal diseases, treatment with H2S donors could restore H2S levels and improve renal functions by preventing oxidative stress, inflammation, and necrosis by reducing superoxide formation, lipid peroxidation, iNOS, NF-κB, TNF-α, and malondialdehyde levels [24,30]. This evidence concerns the gene NFKB1 and kidney disorder.